Negative regulation of the JAK/STAT pathway

BioEssays

Volumn 21, Issue 1, 1999, Pages 47-52

  Starr, Robyn ^a   Hilton, Douglas J ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

ANIMAL; CELL DIFFERENTIATION; HEMATOPOIESIS; HUMAN; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; HEMATOPOIESIS; HUMANS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0032966863     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199901)21:1<47::AID-BIES6>3.0.CO;2-N     Document Type: Review

References (44)

1. Nicola NA, Guidebook to cytokines and their receptors. Oxford: Oxford University Press; 1994.
2. Darnell JEJ. STATs and gene regulation. Science 1997;277:1630-1635.
3. Pellegrini S, Dusanter-Fourt I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur J Biochem 1997;248:615-633.
4. Shuai K, Schindler C, Prezioso VR, Darnell JE Jr. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91kDa DNA binding protein. Science 1992;259:1808-1812.
5. Goldstein JL, Brown MS, Anderson RG, Russell DW, Schneider WJ. Receptor mediated endocytosis. Annu Rev Cell Biol 1985;1:1-39.
6. Tojo A, Kasuga M, Urabe A, Takaku F. Vanadate can replace interleukin 3 for transient growth of factor-dependent cells. Exp Cell Res 1987;171: 16-23.
7. Frearson JA, Alexander DR. The role of phosphotyrosine phosphatases in haematopoietic cell signal transduction. BioEssays 1997;19:417-427.
8. Shultz LD, Rajan TV, Greiner DL. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends Biotechnnol 1997;15:302-307.
9. Shultz LD, Schweitzer PA, Rajan TV, Yi T Ihle JN, Matthews RJ, Thomas ML, Beier DR. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993; 73:1445-1454.
10. Tsui HW, Siminovitch KA, de Souza L, Tsui FW. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genet 1993;4:124-129.
11. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivatior of JAK2 and termination of proliferative signals. Cell 1995;80:729-738.
12. Yi T, Mui AL, Krystal G, Ihle JN. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 1993;13:7577-7586.
13. David M, Chen HE, Goelz S, Larner AC, Neel BG. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1995;15:7050-7058.
14. Chen HE, Chang S, Trub T, Neel BG. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1996;16:3685-3697.
15. Paulson RF, Vesely S, Siminovitch KA, Bernstein A. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nature Genet 1996;13:309-315.
16. Jiao H, Berrada K, Yang W, Tabrizi M, Platanias LC, Yi T. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain containing protein tyrosine phosohatase SHP-1. Mol Cell Biol 1996;16:6985-6992.
17. de la Chapelle A, Traskelin AL, Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign erythrocytosis. Proc Natl Acad Sci USA 1993;90:4495-4499.
18. You M, Zhao ZZ. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-gamma-stimulated activation of STAT transcription factors in HeLa cells. J Biol Chem 1997;272:23376-23381.
19. Symes A, Stahl N, Reeves SA, Farruggella T, Servidei T, Gearan T, Yancopoulous G, Fink JS. The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression. Curr Biol 1997;7:697-700.
20. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. A family of cytokine-inducible inhibitors of signalling. Nature 1997;387:917-921.
21. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997;387:921-924.
22. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997;387:924-929.
23. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D, Nicola NA. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA 1998;95:114-119.
24. Masuhara M, Sakamoto H, Matsumoto A, Suzuki R, Yasukawa H, Mitsui K, Wakioka T, Tanimura S, Sasaki A, Misawa H, Yokouchi M, Ohtsubo M, Yoshimura A. Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun 1997;239:439-446.
25. Minamoto S, Ikegame K, Ueno K, Narazaki M, Naka T, Yamamoto H, Matsumoto T, Saito H, Hosoe S, Kishimoto T. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochem Biophys Res Commun 1997;237:79-83.
26. Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T, Miyajima A. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J 1995;14:2816-2826.
27. Adams TE, Hansen JA, Starr R, Nicola NA, Hilton DJ, Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3 a novel inhibitor of cytokine receptor signaling. J Biol Chem 1998;273:1285-1287.
28. Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A, Yoshimura A. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STATS activation. Blood 1997;89:3148-3154.
29. Quelle FW, Wang D, Nosaka T, Thierfelder WE, Stravopodis D, Weinstein Y, Ihle JN. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol Cell Biol 1996;16:1622-1631.
30. Ohya K, Kajigaya S, Yamashita Y, Miyazato A, Hatake K, Miura Y, Ikeda U, Shimada K, Ozawa K, Mano H. SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase. J Biol Chem 1997;272:27178-27182.
31. Matuoka K, Miki H, Takahashi K, Takenawa T. A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signalling motifs. Biochem Biophys Res Commun 1997;239:488-492.
32. Pallard C, Gouilleux F, Benit L, Cocault L, Souyri M, Levy D, Groner B, Gisselbrecht S, Dunsanter-Fourt I. Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J 1995;14:2847-2856.
33. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K. Specific inhibition of Stat3 signal transduction by PIAS3. Science 1997;278:1803-1805.
34. Valdez BC, Henning D, Perlaky L, Busch RK, Busch H. Cloning and characterization of Gu/RH-II binding protein. Biochem Biophys Res Commun 1997;234:335-340.
35. Shuai K, Stark GR, Kerr IM, Darnell JE Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 1993;261:1744-1746.
36. David M, Grimley PM, Finbloom DS Larner AC. A nuclear tyrosine phosphatase downregulates interferon-induced gene expression. Mol Cell Biol 1993;13:7515-7521.
37. Haque SJ, Flati V, Deb A, Williams BRG. Roles of protein-tyrosine phosphatases in Stat1a-mediated cell signalling. J Biol Chem 1995;270: 25709-25714.
38. Lee C-K, Bluyssen HAR, Levy DE. Regulation of interferon-a responsiveness by the duration of Janus kinase activity. J Biol Chem 1997;272:21872-21877.
39. Haspel RL, Salditt-Georgieff M, Darnell JE Jr. The rapid inactivation of nuclear tyrosine phosphorylated Stal1 depends upon a protein tyrosine phosphatase. EMBO 1996;15:6262-6268.
40. Shuai K, Liao J, Song MM. Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol Cell Biol 1996;16:4932-4941.
41. Caldenhovsn E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JAM, Lammers JWJ, Koenderman L, de Groot RP. STAT3beta, a splice variant of transcription factor STAT3:is a dominant negative regulator of transcription. J Biol Chem 1996;271:13221-13227.
42. Wang D, Stravopodis D, Teglund S, Kitazawa J, Ihle JN. Naturally occurring dominant negative variants of Stat5. Mol Cell Biol 1996;16:6141-6148.
43. Kim TK, Maniatis T. Regulation of interferon-γ-activated STAT1 by the ubiquitin-proteasome pathway. Science 1996;273:1717-1719.
44. Yu C-L, Burakoff SJ. Involvement of proteasomes in regulating Jak/STAT pathways upon interleukin-2 stimulation. J Biol Chem 1997;272:14017-14020.